Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News AHA 2020

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

Todd Neale

November 15, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

Caitlin E. Cox

December 24, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Shelley Wood

October 29, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Conference News SCCT 2018

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Yael L. Maxwell

July 16, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

Advertisement

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content